Early Initiation of Letermovir Prophylaxis Prevents Cytomegalovirus Infection After Liver Transplantation: A Prospective Single-Center Study (TTS 2026) - Sep 17, 2026 - Pres time: Sep 22, 2026; 08:45 AM - 08:50 AM; Location: Room C4.8; 312; "Treatment was discontinued in cases of adverse events, CMV antigenemia, or CMV disease, with conversion to ganciclovir or valganciclovir as appropriate. Early initiation of letermovir prophylaxis within 2 weeks after liver transplantation effectively prevents CMV infection and is a safe strategy. These findings highlight the critical importance of early prophylactic intervention in optimizing CMV prevention."
Clinical • Cytomegalovirus Infection • Hepatology • Infectious Disease • Transplantation
|
|
Katsunori Sakamoto1; Takashi Ito1; Shinya Okumura1; Hidenobu Kojima1; Daisuke Ueda1; Koh Shinohara2; Masaaki Hirata1; Ryo Ataka1; Tokuyuki Yamashita1; Jun Ichikawa1; Hiroki Aoyama1; Satoshi Ogiso1; Tatsuya Okamoto1; Yoichiro Uchida1; Takamichi Ishii1; Miki Nagao2; Etsuro Hatano1
|